>>> Up
* Barratt Raised to Buy at HSBC; PT 570 pence
* BayWa Raised to Buy at M.M. Warburg; PT 49.50 euros (+)
* Bellway Raised to Buy at HSBC; PT 2,700 pence
* Berkeley Raised to Hold at HSBC; PT 4,000 pence
* Billerud Raised to Buy at DNB Markets; PT 124 kronor
* Crest Nicholson Raised to Buy at HSBC; PT 270 pence
* DraftKings Raised to Neutral at Exane; PT $17
* Klepierre Raised to Overweight at Barclays; PT 24 euros
* LVMH Raised to Hold at SBG Securities; PT 880 euros (+)
* Novo Nordisk Raised to Outperform at Credit Suisse
* Persimmon Raised to Buy at HSBC; PT 1,550 pence
* Redrow Raised to Buy at HSBC; PT 670 pence
* Romande Energie Raised to Buy at Baader Helvea
* SEB Raised to Hold at Deutsche Bank; PT 126 kronor
* SFS Raised to Buy at Stifel; PT 135 Swiss francs
* SGS Cut to Add at AlphaValue/Baader
* Taylor Wimpey Raised to Buy at HSBC; PT 150 pence
* WWE Raised to Overweight at Morgan Stanley; PT $120
>>> Down
* Barry Callebaut Cut to Equal-Weight at Barclays
* Britvic Downgraded to Hold at Peel Hunt on Full Valuation
* Industrials REIT Cut to Hold at Berenberg
* Knorr-Bremse Cut to Hold at SocGen
* LyondellBasell Cut to Hold at Jefferies; PT $90
* Verallia Cut to Neutral at Exane; PT 44 euros (+)
* Wood Cut to Hold at Canaccord; PT 240 pence (+)
>>> Initiation
* American Express Rated New Hold at Baptista Research; PT $181
* ASAI SS Rated New Buy at Pareto Securities; PT 2.30 kronor
* BlackRock Rated New Hold at Baptista Research; PT $703
>>> Call
* Citi Opens Positive Catalyst Watches on STMicro, Ericsson for 1Q
* Gjensidige Offers Quality at a Discount, Jefferies Upgrades
* HSBC Upgrades Seven UK Housebuilders With Downturn Priced-In (+)
* Novo Nordisk Growth Can’t Be Ignored, Raised at Credit Suisse
* Sobi Raised to Outperform at RBC on Revised Beyfortus Agreement
* EssilorLuxottica Rated Overweight at JPMorgan on Robust Outlook
* Nordea, Danske Top Nordic Bank Picks at Deutsche; SEB Upgraded (+)
* Verallia Cut to Neutral as Exane Gets Picky in Glass Producers (+)
* WWE Raised at MS on Attractive Risk/Reward in UFC Merger (+)